NASDAQ: GPCR

Market Summary

Should investors be concerned about GPCR’s high price-to-sales ratio?

Arcelia Reed

Structure Therapeutics Inc ADR (GPCR)’s stock is trading at $92.35 at the moment marking a rise of 4.19% from the ...

Stocks Trading

Experts predict Structure Therapeutics Inc ADR’s (GPCR) current quarter earnings growth rate

Arcelia Reed

In the current trading session, Structure Therapeutics Inc ADR’s (GPCR) stock is trading at the price of $67.25, a gain ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.